The present study was designed to evaluate the chemotherapy-induced cellular immunosuppression in 20 children with acute lymphoblastic leukemia (ALL) in remission and receiving maintenance chemotherapy. Peripheral blood was serially obtained from leukemic children during vincristine/cyclophosphamide/6-mercaptopurine/prednisone combined consolidation chemotherapy. The mean absolute number of peripheral blood lymphocytes as well as the mean absolute numbers of lymphocyte subsets (T cells, T cell subsets, B cells, and natural killer cells) from leukemic children before consolidation chemotherapy were all significantly lower than in control subjects; however, the percentages of lymphocyte subsets were similar in both groups. After consolidation chemotherapy, the percentages of CD4+ T lymphocytes and natural killer (NK) cells were significantly decreased and the percentages of monocytes and CD8+ T lymphocytes were significantly increased. Phytohemagglutinin- and 12-O-tetradecanoylphorbol-13-acetate-induced production of interleukin-2 (IL-2) and NK-cell-mediated cytotoxic activity by peripheral blood mononuclear cells (PBMC) were also substantially decreased in the post-therapy groups. NK activity correlated with the percentage of NK cells in PBMC. In contrast, OK432-induced production of tumor necrosis factor α (TNFα) and killer activity against NK-resistant target cells were significantly increased after therapy as compared with the pre-therapy and control groups. TNFα production correlated with the percentage of monocytes in PBMC. These results demonstrate that substantial quantitative and qualitative chemotherapy-induced abnormalities of the cellular immune system are present in the majority of patients treated with ALL. It is also suggested that the increased TNFα production by monocytes and the appearance of potent killing activity against NK-resistant targets might compensate for the defects of IL-2 production and NK activity during intensive consolidation chemotherapy.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Arya SK, Wong-Staar F, Gallo RC (1984) Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 133: 273
Azuma E, Kaplan J (1988) Role of lymphokine activated killer cells as mediators of veto and natural suppression. J Immunol 142: 2601
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977
Borzy MS, Ridgway D (1989) Prolonged defects of interleukin-2 production, responsiveness, and receptor expression in patients with acute lymphoblastic leukemia. Blood 73: 1608
Dupont E, Huygen K, Schandene L, Vandercruys M, Palfliet K, Wybran J (1985) Influence of in vivo immunosuppressive drugs on production of lymphokines (1985) Transplantation 39: 143
Dupont E, Scandene L, Denys C, Wybran J (1986) Differential in vitro actions of cyclosporin, methylprednisolone, and 6-mercaptopurine: implications for drugs' influence on lymphocyte activation mechanisms. Clin Immunol Immunopathol 40: 422
Feldman S, Hughes WT, Kim HY (1973) Herpes zoster in children with cancer. Am J Dis Child 126: 178
Grills S, Crabtree GR, Smith KA (1979) Glucocorticoid-induced inhibition of T cell growth factor production: I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 123: 1624
Guillou PJ, Giles GR, Ramsden CW (1986) Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production on cyclosporin treated and conventionally immunosuppressed human allograft recipients. J Clin Immunol 6: 373
Hardy C, Feusner J, Harada S, Sanger W, Von Schmidt B, Yetz J, Saemundsen A, Lennette E, Linder J, Skeeley JK, Lubin B, Purtilo DT (1984) Fetal Epstein-Barr virus-induced lymphoproliferation complicating acute lymphoblastic leukemia. J Pediatr 105: 64
Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86: 3803
Hayashi H, Kiyota T, Sakamoto H, Seto M (1985) An enzyme-linked immunosorbent assay for recombinant human tumor necrosis factor using monoclonal antibody. In: Seto M, Asahi C (eds) Recent advances in chemotherapy. Tokyo, Japan, p 820
Hughes WT, Feldman S, Cox F (1974) Infectious disease in children with cancer. Pediatr Clin North Am 21: 583
Ichimura O, Suzuki S, Saito M, Sugawara Y, Ishida N (1985) Augmentation of interleukin 1 and interleukin 2 production by OK-432. Int J Immunopharmacol 7: 263
Kaplan MP, Lysz K, Rosenberg SA, Rosenberg JC (1983) Suppression of interleukin-2 production by methylprednisone. Transplant Proc 15: 407
Kiyohara T, Taniguchi K, Kubota S, Koga S, Sakurai T, Saitoh Y (1988) Induction of lymphokine-activated killer-like cells by cancer chemotherapy. J Exp Med 168: 2355
Lee SW, Tsou A-P, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC (1988) Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 85: 1204
Mantovani A, Luini W, Peri G, Vecchi A, Spreafico F (1978) Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice. J Natl Cancer Inst 61: 1255
Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H, Uchino H (1985) Interleukin-2 receptor (Tac antigen) expressed in adult T-cell leukemia cells. J Clin Invest 76: 446
This work was supported by a grant-in-aid for cancer research from the Ministry of Health and Welfare, Japan, and a grant-in-aid from the Association for the Support of Children with Cancer
About this article
Cite this article
Komada, Y., Zhang, S., Zhou, Y. et al. Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy. Cancer Immunol Immunother 35, 271–276 (1992). https://doi.org/10.1007/BF01789334
- Acute lymphoblastic leukemia